AzTrials
AzTrials

Dental ImplantAINCT07459036

Artificial Intelligence-Guided Versus Manual CBCT Planning for Immediate Implant Placement

A study testing AI assisted CBCt and Manual CBCT segmentation in people with Dental Implant and Immediate Implant, run by Shalash Dental education at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study evaluates whether artificial intelligence (AI)-based analysis of cone-beam computed tomography (CBCT) scans can support clinical decision-making for immediate dental implant placement in molar extraction sites. Read more about this study

Who is it for?
Ages 18 to 99 yearsHealthy volunteers can take part
What is being tested?
AI assisted CBCt and Manual CBCT segmentation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteEgypt
Study dates
3 Mar 2026to 2 May 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 99 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Adults≥18 years are able to provide informed consent. Indicated for the extraction of a molar tooth (maxillary or mandibular) with planned implant-supported rehabilitation.
  • Candidate for immediate implant placement attempt based on preoperative clinical evaluation and CBCT availability.
  • Preoperative CBCT will be acquired using the study imaging protocol within a defined window (e.g., ≤4 weeks before surgery).
  • Adequate oral hygiene and periodontal condition compatible with implant surgery (e.g., treated/stable periodontal status per clinician judgement).

Who cannot join

  • Pregnancy or breastfeeding (due to imaging/surgical considerations).
  • Uncontrolled systemic disease or medical contraindication to oral surgery/implant placement (e.g., uncontrolled diabetes, immunosuppression as judged by clinician).
  • History of head and neck radiotherapy in the implant region. Use of medications associated with compromised bone healing where immediate implant placement is not advised (e.g., high-dose antiresorptives/IV bisphosphonates; you can specify per your clinic policy).
  • Acute uncontrolled infection at the site requiring staged management (e.g., spreading cellulitis/abscess) or other condition precluding immediate placement per surgeon judgement.
  • Need for simultaneous major augmentation that precludes immediate implant placement (e.g., extensive ridge reconstruction planned at the same surgery rather than socket-level grafting).
  • Inadequate CBCT quality for segmentation/measurement (motion artifacts, incomplete field of view, or metal artifact obscuring the septum).

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Shalash Implant education

    Cairo

Other trials in Egypt

About this study

Official title: Artificial Intelligence-Guided Versus Manual CBCT Planning for Immediate Implant Placement in Molar Extraction Sites: A Randomized Controlled Trial

This study evaluates whether artificial intelligence (AI)-based analysis of cone-beam computed tomography (CBCT) scans can support clinical decision-making for immediate dental implant placement in molar extraction sites.

When a molar tooth is removed, placing a dental implant immediately may reduce treatment time and preserve surrounding bone. However, immediate implant placement is not always possible and depends on the anatomy of the extraction socket, particularly the interradicular septum (the bone between the roots). CBCT imaging is routinely used to assess this anatomy before surgery. Traditionally, radiologists manually evaluate these scans. Recently, AI-based tools have been developed to automatically analyze CBCT images.

Read more

In this randomized controlled trial, patients requiring molar extraction and potential immediate implant placement will be assigned to one of two planning approaches: AI-guided CBCT assessment or conventional manual CBCT assessment. The operating surgeon will use the assigned planning report to guide treatment decisions.

The primary outcome of the study is the feasibility of immediate implant placement, defined as successful implant placement with achievement of primary stability during surgery. Secondary outcomes include surgical time, need for changes to the treatment plan, and implant stability measurements.

The goal of this study is to determine whether AI-assisted CBCT analysis performs similarly to, or improves upon, conventional manual radiologic assessment in supporting safe and effective immediate implant placement.

Read the detailed description

This study is a prospective, parallel-arm, randomized controlled clinical trial designed to evaluate the clinical impact of artificial intelligence (AI)-based CBCT analysis on decision-making for immediate implant placement in molar extraction sites.

Following eligibility confirmation and informed consent, participants requiring molar extraction with potential immediate implant placement will undergo standardized preoperative cone-beam computed tomography (CBCT) imaging. Participants will be randomly allocated in a 1:1 ratio to one of two planning workflows:

AI-guided planning arm: CBCT scans will be analyzed using a pre-specified, locked AI-based segmentation and socket assessment model. The AI system will quantify interradicular septum dimensions and generate a feasibility classification based on predefined anatomical criteria.

Manual planning arm: CBCT scans will undergo conventional manual segmentation and assessment by an experienced radiologist using the same predefined anatomical criteria for feasibility determination.

In both arms, feasibility recommendations will be based on identical, prospectively defined decision thresholds to ensure comparability between planning methods. The operating surgeon will receive only the planning report corresponding to the assigned allocation.

All surgeries will be performed according to a standardized surgical protocol. The primary outcome is intraoperative feasibility of immediate implant placement, defined as successful implant placement in the extraction socket with achievement of primary stability according to prespecified stability criteria documented in the operative record. Cases in which implant placement is not performed or is aborted due to inability to achieve adequate primary stability will be classified as non-feasible.

Secondary outcomes include operative time, need for intraoperative modification of the treatment plan, insertion torque values, and any intraoperative complications.

Outcome assessment will be performed by an independent assessor blinded to allocation. AI analysis will be conducted using a locked model without post hoc modification.

The study aims to determine whether AI-guided CBCT planning is non-inferior or superior to conventional manual CBCT assessment in supporting immediate implant placement decisions.

Being tested
AI assisted CBCt, Manual CBCT segmentation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • AI assisted CBCtDevice

    The intervention consists of a fully automated, deep learning-based CBCT analysis pipeline designed for extraction socket segmentation and quantitative interradicular septum assessment.

    The AI system utilizes a pre-trained convolutional neural network architecture to perform voxel-level segmentation of the extraction socket and surrounding alveolar structures on CBCT datasets. Following segmentation, the model automatically quantifies predefined anatomical parameters, including interradicular septum width at standardized reference levels and socket morphology classification. These measurements are generated using algorithmically defined geometric landmarks, ensuring consistent spatial reference across cases.

    Feasibility for immediate implant placement is determined using a prespecified, protocol-defined decision rule applied to AI-derived quantitative parameters.

  • Manual CBCT segmentationProcedure or surgery

    The control intervention consists of conventional radiologic evaluation of CBCT datasets using manual segmentation and operator-driven anatomical assessment.

    CBCT scans will be reviewed by an experienced oral and maxillofacial radiologist using standard imaging software. Interradicular septum dimensions will be determined through manual identification of anatomical landmarks and measurement using software-based calipers at predefined reference levels. Socket morphology classification will be assigned based on visual interpretation and application of the same predefined anatomical criteria specified in the study protocol.

    Feasibility for immediate implant placement will be determined by applying the protocol-defined decision thresholds to manually obtained measurements. All measurements and classifications will be documented in a structured planning report provided to the operating surgeon.

    Unlike the AI-guided intervention, this workflow relies on manual landmark identification and ope

Study groups in NCT07459036
Study groupRoleWhat they receive
AI assisted CBCTExperimentalParticipants randomized to this arm will undergo preoperative cone-beam computed tomography (CBCT) imaging as part of standard diagnostic workup for molar extraction with potential immediate implant placement. CBCT datasets will be processed using a pre-specified, locked artificial intelligence (AI)-based segmentation and socket assessment model. The AI system will automatically segment the extraction socket anatomy, quantify interradicular septum dimensions, and generate a structured feasibility assessment according to predefined anatomical decision thresholds established in the study protocol. A standardized AI-generated planning report, including septum measurements and feasibility classification, will be provided to the operating surgeon prior to surgery. The surgeon will use this report to guide preoperative planning and intraoperative decision-making. Surgical procedures will be performed according to a standardized surgical protocol. Immediate implant placement will be attempte
Receives: Device: AI assisted CBCt
Manual CBCT segmentedActive comparatorParticipants randomized to this arm will undergo preoperative CBCT imaging as part of the standard diagnostic workup for molar extraction with potential immediate implant placement. CBCT datasets will be evaluated using conventional manual segmentation and radiologic assessment performed by an experienced radiologist. Interradicular septum dimensions and socket morphology will be assessed according to predefined anatomical criteria specified in the study protocol. Feasibility for immediate implant placement will be determined using the same prospectively defined decision thresholds applied in the intervention arm. A standardized manual planning report, including septum measurements and feasibility classification, will be provided to the operating surgeon before surgery. The surgeon will use this report to guide preoperative planning and intraoperative decision-making. Surgical procedures will be performed according to the same standardized surgical protocol
Receives: Procedure: Manual CBCT segmentation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Immediate implant feasability

    Proportion of sites with successful immediate implant placement with primary stability at the index surgery (feasible vs not feasible).

    Measured: During the implant surgery-intra operative after flap elevation

Secondary outcomes (1)
  1. Planning time (minutes)

    Time to generate the report (AI processing time vs manual segmentation/assessment time).

    Measured: Preoperative before the surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Mar 2026
  2. Study start3 Mar 2026
  3. Primary completion2 Apr 2026
  4. Study completion2 May 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
80 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07459036
Sponsor's protocol ID
5-9-23
Acronym
AI
Status last verified
Mar 2026
First submitted
1 Mar 2026
Last updated
30 Sep 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing AI assisted CBCt and Manual CBCT segmentation in people with Dental Implant and Immediate Implant, run by Shalash Dental education at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Immediate implant feasability (time frame: During the implant surgery-intra operative after flap elevation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in